Neuroprotection by the Immunomodulatory Drug Pomalidomide in the
Drosophila
LRRK2
Parkinson
drug repurposing
immunomodulation
neuroprotection
repositioning
Journal
Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824
Informations de publication
Date de publication:
2020
2020
Historique:
received:
20
11
2019
accepted:
03
02
2020
entrez:
3
3
2020
pubmed:
3
3
2020
medline:
3
3
2020
Statut:
epublish
Résumé
The search for new disease-modifying drugs for Parkinson's disease (PD) is a slow and highly expensive process, and the repurposing of drugs already approved for different medical indications is becoming a compelling alternative option for researchers. Genetic variables represent a predisposing factor to the disease and mutations in leucine-rich repeat kinase 2 (LRRK2) locus have been correlated to late-onset autosomal-dominant PD. The common fruit fly
Identifiants
pubmed: 32116655
doi: 10.3389/fnagi.2020.00031
pmc: PMC7031158
doi:
Types de publication
Journal Article
Langues
eng
Pagination
31Informations de copyright
Copyright © 2020 Casu, Mocci, Isola, Pisanu, Boi, Mulas, Greig, Setzu and Carta.
Références
Open Biochem J. 2011;5:37-44
pubmed: 21792375
Front Mol Neurosci. 2014 May 27;7:49
pubmed: 24904275
Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):1022-3
pubmed: 19152345
Microsc Res Tech. 1999 Apr 15;45(2):106-21
pubmed: 10332728
JAMA Neurol. 2018 Nov 1;75(11):1416-1422
pubmed: 30039155
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12703-8
pubmed: 23858438
Cell Rep. 2019 Feb 12;26(7):1774-1786.e4
pubmed: 30759389
Annu Rev Genet. 2005;39:153-71
pubmed: 16285856
J Parkinsons Dis. 2013 Jan 1;3(3):231-9
pubmed: 24018336
Prog Brain Res. 2010;184:325-41
pubmed: 20887883
Cancer Chemother Pharmacol. 2019 Nov;84(5):1073-1087
pubmed: 31493176
Blood Cancer J. 2013 Sep 06;3:e143
pubmed: 24013664
Biochem Soc Trans. 2019 Apr 30;47(2):651-661
pubmed: 30837320
Genome Biol Evol. 2014 Feb;6(2):273-89
pubmed: 24443439
Neurochem Res. 2017 Feb;42(2):686-696
pubmed: 27943027
Lancet. 2004 May 29;363(9423):1802-11
pubmed: 15172781
Front Neurol. 2018 Oct 15;9:860
pubmed: 30459700
J Exp Med. 1993 Jun 1;177(6):1675-80
pubmed: 8496685
J Neural Transm (Vienna). 2011 May;118(5):795-808
pubmed: 21552986
Onco Targets Ther. 2013 May 10;6:531-8
pubmed: 23690693
PLoS One. 2011;6(6):e21519
pubmed: 21738687
J Neurosci Res. 2013 May;91(5):671-80
pubmed: 23404341
Semin Immunol. 2014 Jun;26(3):267-74
pubmed: 24981286
Neuron. 2006 Mar 16;49(6):833-44
pubmed: 16543132
Mov Disord. 2019 Dec;34(12):1818-1830
pubmed: 31335998
Front Neurosci. 2010 Dec 08;4:205
pubmed: 21165178
J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):223-36; discussion 222
pubmed: 11983801
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2693-8
pubmed: 18258746
Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):
pubmed: 28716886
Curr Opin Neurobiol. 2002 Dec;12(6):633-8
pubmed: 12490252
Biochem Soc Trans. 2012 Oct;40(5):1047-51
pubmed: 22988863
Int J Mol Sci. 2018 Oct 19;19(10):
pubmed: 30347766
Neurol Sci. 2014 Oct;35(10):1495-504
pubmed: 25027012
Curr Biol. 2002 Jul 23;12(14):1263-8
pubmed: 12176339
Biochem Soc Trans. 2012 Oct;40(5):1086-9
pubmed: 22988870
Neural Regen Res. 2018 Sep;13(9):1493-1506
pubmed: 30127102
J Immunol. 2010 Nov 1;185(9):5577-85
pubmed: 20921534
Nat Rev Drug Discov. 2019 Jan;18(1):41-58
pubmed: 30310233
Br J Haematol. 2020 Feb;188(4):483-485
pubmed: 31566715
PLoS One. 2016 Jan 04;11(1):e0146140
pubmed: 26727265
Mol Neurodegener. 2016 Dec 7;11(1):73
pubmed: 27927216
Oncotarget. 2016 May 31;7(22):33237-45
pubmed: 27120781
Curr Top Dev Biol. 2017;121:173-200
pubmed: 28057299
Cell Transplant. 2019 Apr;28(4):439-450
pubmed: 31094216
Front Neural Circuits. 2009 Jul 01;3:5
pubmed: 19597562
J Exp Med. 1991 Mar 1;173(3):699-703
pubmed: 1997652
J Neuroinflammation. 2012 May 29;9:106
pubmed: 22642825
Bioessays. 2009 Dec;31(12):1327-36
pubmed: 19921660
Birth Defects Res B Dev Reprod Toxicol. 2007 Jun;80(3):188-207
pubmed: 17570132
Oncogene. 2013 Sep 5;32(36):4191-202
pubmed: 23318436
Sci Rep. 2017 Jul 14;7(1):5377
pubmed: 28710481
Cell. 2005 Apr 8;121(1):141-52
pubmed: 15820685
FASEB J. 2017 Jan;31(1):172-179
pubmed: 27671228
FEBS J. 2009 Nov;276(22):6455-63
pubmed: 19804413
CNS Neurol Disord Drug Targets. 2011 May;10(3):391-403
pubmed: 21288189
J Cell Sci. 2015 Feb 1;128(3):541–52
pubmed: 25501810
Antioxid Redox Signal. 2016 Jul 10;25(2):61-77
pubmed: 27009601
J Biol Chem. 2016 Sep 23;291(39):20811-21
pubmed: 27528608
Curr Opin Neurobiol. 2000 Dec;10(6):790-5
pubmed: 11240291
Expert Opin Drug Saf. 2012 Jan;11(1):107-20
pubmed: 22066855
Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5164-E5173
pubmed: 29760073
Biochem J. 2012 Aug 15;446(1):99-111
pubmed: 22612223
Bioorg Med Chem. 2018 May 1;26(8):1547-1559
pubmed: 29472124
Br J Haematol. 2020 Feb;188(4):501-510
pubmed: 31588567
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):E4820
pubmed: 24471177
Neurobiol Aging. 2015 Mar;36(3):1559-68
pubmed: 25660193
Mol Cell Biol. 2014 Jun;34(12):2147-61
pubmed: 24687852
Int J Mol Sci. 2019 Jan 24;20(3):
pubmed: 30682785
Acta Neuropathol Commun. 2015 Dec 14;3:84
pubmed: 26666562
Curr Alzheimer Res. 2017;14(4):403-411
pubmed: 28124585
Br J Pharmacol. 2018 Aug;175(16):3298-3314
pubmed: 29570770
Front Mol Neurosci. 2018 Apr 27;11:144
pubmed: 29755317
Expert Rev Anticancer Ther. 2014 May;14(5):499-510
pubmed: 24738833
J Neurochem. 2016 Oct;139 Suppl 1:59-74
pubmed: 27090875
Immunol Lett. 2016 Feb;170:42-51
pubmed: 26730849
J Cell Biol. 2009 Jul 13;186(1):129-45
pubmed: 19596851
J Neuroinflammation. 2016 Jun 28;13(1):168
pubmed: 27353053
Neuron. 2003 Sep 11;39(6):889-909
pubmed: 12971891
Exp Cell Res. 2008 Jun 10;314(10):2055-65
pubmed: 18445495
Lancet. 2009 Jun 13;373(9680):2055-66
pubmed: 19524782
J Neurosci. 2012 Feb 1;32(5):1602-11
pubmed: 22302802
Curr Alzheimer Res. 2007 Sep;4(4):378-85
pubmed: 17908040
Front Immunol. 2014 Sep 23;5:459
pubmed: 25295041
Prog Neurobiol. 2017 Aug;155:57-75
pubmed: 27107797
J Neuroinflammation. 2015 May 14;12:93
pubmed: 25966683
Blood. 2013 Jan 31;121(5):858
pubmed: 23372151